COVID Treatment Program
The Baltimore Convention Center Field Hospital (BCCFH) - COVID Task Force operates an outpatient COVID-19 treatment program with three main service lines:
- A COVID-19 treatment infusion center
- A self-referral telehealth COVID-19 treatment program for people who are not able to see a provider in timely way
- Test to Treat Program at State Center for symptomatic patients who test positive and are at high risk for severe COVID-19 infections
BCCFH Infusion Center
Located at the intersection of Greene and Lombard Streets on the University of Maryland Medical Center Downtown Campus (see map below), the BCCFH COVID-19 Infusion Center provides monoclonal antibody (mAb) therapy to patients age 12 and older with positive COVID-19 tests who meet the criteria for this treatment.
The BCCFH COVID Task Force also partners with other sites across the state to provide monoclonal antibody therapy at locations most convenient to patients, including scheduling patients at the Upper Chesapeake Medical Center's infusion center in Bel Air, MD.
Medical providers: Use the yellow button below to refer patients directly for infusion treatment.
Our Care Coordination Team will review the referral form and contact the patient to coordinate services as soon as possible. Providers should alert their patients to expect a call from us. We will do everything we can to send providers timely notification whether we will be able to schedule referred patients. To expedite this, please provide us with an email address that you check frequently.
Note: In the near future, the Infusion Center will also provide Remdesivir treatment for patients.
For Providers: Infusion Center Referral Form
BCCFH Self-Referral Telehealth Program
This program offers access to COVID-19 treatments to patients age 18 and older who do not have medical providers or are not able to get a timely appointment with their doctors.
Patients: Contact our Care Coordination Team by calling 410-649-6122 Monday through Friday 8 am to 5 pm or clicking on the yellow button below to complete the online self-referral form below.
All self-referrals will be reviewed, and patients who may qualify for any of the COVID-19 treatments will be scheduled for a telehealth visit with one of our providers.
At that visit, providers will work with patients to determine the best course of treatment for their COVID-19 illness. Patients should make sure to enter an accurate telephone number and email address so the Care Coordination Team can reach you.
For Patients: Self-Referral for COVID Treatment
Test to Treat Program at State Center
During all testing sessions at State Center, you will have the chance to see a medical provider for COVID treatment. Only patients who are feeling sick, have a positive rapid test result and are at high risk of severe COVID illness qualify for treatment.
Medical providers will meet with you to determine the which of the treatments below may be best for you. We have oral medications we can give you (Paxlovid and Molnupiravir) or we can schedule you for a monoclonal antibody infusion treatment, which is given through an IV, at the BCCFH Infusion Center.
You will need to bring a complete list of medications you take to your testing appointment. If you qualify for treatment, your visit might last an hour or more if the line is very long.
Although our services are free, if you have insurance, we may bill your insurance for the visit, so bring your insurance card. But you do not need to have insurance to be tested and treated.
COVID Treatment Type
Monoclonal Antibody Treatment (IV Therapy)
Authorized by the Federal Drug Administration (FDA) under an Emergency Use Authorization (EUA), monoclonal antibody infusion is an outpatient treatment that has been demonstrated to reduce COVID-19 hospitalization or emergency room visits when given within a specific number of days from symptom onset.
Currently, these treatments are approved for patients 12 and older who have positive COVID-19 test results, have mild-to-moderate symptoms not requiring hospitalization and are considered to be at high risk of hospitalization or death from COVID-19. Monoclonal antibody therapy is administered by IV (through a vein).
The BCCFH Infusion Center provides monoclonal antibody therapy that is effective for the most prevalent circulating strain(s) of COVID-19 in Maryland. Currently, the BCCFH treats COVID-19 with bebtelovimab, which must be infused within seven days of symptom onset.
You can learn more about the medication by reading the FDA Bebtelovimab Provider Fact Sheet or the FDA Bebtelovimab Patient Fact Sheet
Paxlovid (Oral Therapy)
Paxlovid is an outpatient treatment that has been demonstrated to reduce COVID-19 hospitalization or emergency room visits when started within five days from symptom onset.
This oral medication taken twice daily for five days.
This medication was recently given Emergency Use Authorization (EUA) by the FDA for outpatient treatment of COVID-19 in high-risk patients aged 12 and older who have tested positive for COVID-19, have mild-to-moderate symptoms not requiring hospitalization and are considered to be at high risk of hospitalization or death from COVID-19.
This medication is considered first-line therapy for those who meet the EUA criteria. Our medical providers work with patients to determine if this is an appropriate treatment option.
You can learn more about the medication by reading the FDA Paxlovid Provider Fact Sheet or the FDA Paxlovid Patient Fact Sheet.
Molnupiravir (Oral Therapy)
Molnupiravir is an outpatient treatment that has been demonstrated to reduce COVID-19 hospitalization or emergency room visits when started within five days from symptom onset.
This oral medication taken twice daily for five days. This medication was recently given Emergency Use Authorization (EUA) by the FDA for outpatient treatment of COVID-19 in high-risk patients aged 18 and older who have tested positive for COVID-19, have mild-to-moderate symptoms not requiring hospitalization and are considered to be at high risk of hospitalization or death from COVID-19.
Our medical providers work with patients to determine if this is an appropriate treatment option. You can learn more about the medication by reading the FDA Molnupiravir Provider Fact Sheet or the FDA Molnupiravir Patient Fact Sheet.
Cost of Treatment
Treatments at the BCCFH COVID-19 Treatment Program are FREE and patients do not need to have health insurance to receive treatment. If a patient has health insurance, the insurance may be charged for this care, but the patient will not be billed.
Getting to the BCCFH COVID-19 Infusion Center
Patients must have an appointment to come to the treatment center. Walk-ins are not accepted. Please see the information above to learn how to be seen at the treatment center.
The BCCFH COVID-19 Treatment Program can arrange for free transportation to and from appointments for patients who do not have access to safe transportation options. The Care Coordination Team will offer this to patients during the scheduling process.
The Infusion Center is located at the corner of Greene and Lombard Streets in a temporary building. See location on Google Maps.
Arriving and departing patients may be dropped off and picked up in the lot next to the Infusion Center, which is located on Greene Street between Lombard and Pratt. To enter that lot from Green Street, turn left just after you pass Lombard Street.
When you arrive, security personnel will greet you and let you know how to proceed.
Parking
Safe, convenient patient parking is available at several locations near the BCCFH Infusion Center, including:
- The underground University Plaza Garage on West Redwood Street, just opposite University of Maryland Medical Center and the University of Maryland Professional Building, is reserved for patient parking. Validation available to reduce rate to $9.
- Medical Center Garage, Greene St, between Lombard and Pratt shares the same lot as the BCCFH Infusion Center. Validation available to reduce rate to $7.
For more parking options please see Parking at UMMC.
Jointly operated by:
